Showing results (241-250 of 266) with videos related to

Sort By:
Pageof 27
The New England Journal of Medicine|August 29, 1996
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study GroupL Abenhaim, Y Moride, F Brenot, et al.
Revue Des Maladies Respiratoires|March 5, 2018
[Pulmonary veno-occlusive disease]A Boucly, B Girerd, D Bourlier, et al.
Thorax|August 2, 2005
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenolO Sitbon, V V McLaughlin, D B Badesch, et al.
Gut|July 1, 1996
Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind studyJ Thorens, F Froehlich, W Schwizer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 1998
Alternating radiotherapy and chemotherapy in limited disease small cell lung cancerC Le Péchoux, R Arriagada, T Le Chevalier, et al.
The European Respiratory Journal|September 11, 2004
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2M Humbert, R J Barst, I M Robbins, et al.
The New England Journal of Medicine|February 12, 1998
A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study GroupH Decousus, A Leizorovicz, F Parent, et al.
Respiratory Medicine and Research|September 27, 2019
Klippel-Trenaunay syndrome as a rare cause of chronic thromboemboembolic pulmonary hypertensionA Seferian, X Jaïs, L Savale, et al.
The European Respiratory Journal|June 23, 2009
Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive diseaseD Montani, X Jaïs, L C Price, et al.
Annals of the Rheumatic Diseases|March 19, 2009
Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung diseaseB Terrier, M C Tamby, L Camoin, et al.
Pageof 27